Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.

Autor: Moura MS; Department of Pathology, Portuguese Institute of Oncology-Porto, Porto, Portugal., Costa J; Department of Pathology, Portuguese Institute of Oncology-Porto, Porto, Portugal., Velasco V; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Kommoss F; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Oliva E; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Le Loarer F; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France.; Inserm U1312, Université de Bordeaux, Bordeaux, France.; Université de Bordeaux, Talence, France., McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK., Razack R; Division of Anatomical Pathology, National Health Laboratory Service, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Academic Hospital, Cape Town, South Africa., Treilleux I; Department of Pathology, Centre Leon Berard, Lyon, France., Mills A; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA, USA., Longacre T; Department of Surgical Pathology, Stanford University School of Medicine, Stanford, CA, USA., Devouassoux-Shisheboran M; Department of Pathology, CHU Lyon Sud, Pierrebenite, France., Hostein I; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Azmani R; Bioinformatics, Data and Digital Health Department, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Blanchard L; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Hartog C; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Soubeyran I; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Khalifa E; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France., Croce S; Department of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France.; Inserm U1312, Université de Bordeaux, Bordeaux, France.

Publikováno v: Histopathology [Histopathology] 2024 Feb; Vol. 84 (3), pp. 451-462. Date of Electronic Publication: 2023 Nov 21.

High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine

Autor: Grellety, T., Lucchesi, C., Hostein, I., Auzanneau, C., Khalifa, E., Soubeyran, I., Italiano, A.

Publikováno v: In European Journal of Cancer October 2017 84:250-256

Histoséminaire de la Société française de pathologie « Quand les tumeurs pédiatriques et adultes se rejoignent » Cas no 6

Autor: Le Loarer, Francois, Azmani, R., Hostein, I.

Publikováno v: In Annales de Pathologie July 2023 43(4):332-337

The KAT6B::KANSL1 Fusion Defines a New Uterine Sarcoma With Hybrid Endometrial Stromal Tumor and Smooth Muscle Tumor Features.

Autor: Trecourt A; Multi-Site Department of Pathology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Claude Bernard University Lyon 1, Faculty of Medicine Lyon-Sud-Charles, UR 3738 CICLY, Lyon, France., Azmani R; Institute Bergonié, Bioinformatics, Data and Digital Health Department, Comprehensive Cancer Center, Bordeaux, France., Hostein I; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Blanchard L; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Le Loarer F; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France; INSERM Unit 1312, Bordeaux, France; University of Bordeaux, Talence, France., Bourdon A; Institute Bergonié, Bioinformatics, Data and Digital Health Department, Comprehensive Cancer Center, Bordeaux, France., Alame M; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Nadaud B; Multi-Site Department of Pathology, Hospices Civils de Lyon, Lyon Est Hospital, Bron, France., Mayer L; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Rebier F; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Larmonier C; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Moura MS; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), Porto, Portugal., Soubeyran I; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Hartog C; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France., Ray-Coquard I; Claude Bernard University Lyon 1, Faculty of Medicine Lyon-Sud-Charles, UR 3738 CICLY, Lyon, France; Centre Léon Bérard, Department of Medical Oncology, Lyon, France., Treilleux I; Centre Léon Bérard, Department of Biopathology, Lyon, France., Devouassoux-Shisheboran M; Multi-Site Department of Pathology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France; Claude Bernard University Lyon 1, Faculty of Medicine Lyon-Sud-Charles, UR 3738 CICLY, Lyon, France., Croce S; Institute Bergonié, Department of Biopathology, Comprehensive Cancer Center, Bordeaux, France; INSERM Unit 1312, Bordeaux, France. Electronic address: s.croce@bordeaux.unicancer.fr.

Publikováno v: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Oct; Vol. 36 (10), pp. 100243. Date of Electronic Publication: 2023 Jun 10.

Deep learning predicts patients outcome and mutations from digitized histology slides in gastrointestinal stromal tumor.

Autor: Fu Y; Owkin, Inc., New York, NY, USA., Karanian M; Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France., Perret R; Department of Biopathology, Institut Bergonié, Bordeaux, France., Camara A; Owkin, Inc., New York, NY, USA. axel.camara@owkin.com., Le Loarer F; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Jean-Denis M; Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France., Hostein I; Department of Biopathology, Institut Bergonié, Bordeaux, France., Michot A; Department of Surgical Oncology, Institut Bergonié, Bordeaux, France., Ducimetiere F; Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France., Giraud A; Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Bordeaux, France., Courreges JB; Clinical Research and Clinical Epidemiology Unit, Institut Bergonié, Bordeaux, France., Courtet K; Department of Biopathology, Institut Bergonié, Bordeaux, France., Laizet Y; Department of Biopathology, Institut Bergonié, Bordeaux, France., Bendjebbar E; Owkin, Inc., New York, NY, USA., Du Terrail JO; Owkin, Inc., New York, NY, USA., Schmauch B; Owkin, Inc., New York, NY, USA., Maussion C; Owkin, Inc., New York, NY, USA., Blay JY; Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France., Italiano A; Faculty of Medicine, University of Bordeaux, Bordeaux, France.; Department of Medicine, Institut Bergonié, Bordeaux, France., Coindre JM; Department of Biopathology, Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France.

Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2023 Jul 24; Vol. 7 (1), pp. 71. Date of Electronic Publication: 2023 Jul 24.